Gerd Mikus, MD, MSc
Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital of Heidelberg, Im Neuenheimer Feld 410, Heidelberg, Germany
Prof. Mikus received his degrees in Physics (MSc) and Medicine (MD) from the University of Bonn, Germany. He has worked as a clinical pharmacology researcher in institutes (IKP, Stuttgart), universities (Adelaide, Basle) and university hospitals (Heidelberg, Basle). In 1999, he moved to the University of Heidelberg to become the head of the Department’s Clinical Research Unit (KliPS). Since then he has conducted more than 90 clinical trials as principle investigator and more than fifteen first-in-human studies have been successfully carried out in patients and volunteers since 2007. He is currently the deputy head of the department.
His main research focuses on the individualisation of drug therapy by applying phenotyping and genotyping methodologies. Microdosing of CYP probe drugs are currently testet in vaious patient groups including cancer patients.
He is an active member of several scientific societies, also a long term member and now deputy head of the Ethics Committee of the State Chamber of Physicians (Baden-Württemberg). He has published ~220 peer reviewed original articles.